SCHEMBL429838

SCHEMBL429838

Cc1cccc(C(C)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.50
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ACP3 P15309 1/20 0.48
UGT2B7 P16662 1/20 0.48
EPHX1 P07099 1/20 0.46
BRD4 O60885 1/20 0.46
BRD2 P25440 1/20 0.46
CREBBP Q92793 1/20 0.46
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
AOC3 Q16853 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ADRB1 P08588 1/20 0.39
MIF P14174 1/20 0.39
HTR2A P28223 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14087826 1.00 ACHE (0.50) ACHEMEN1KMT2AACP3UGT2B7
SCHEMBL3071260 1.00 ACHE (0.50) ACHEMEN1KMT2AACP3UGT2B7
SCHEMBL343187 1.00 ACHE (0.50) ACHEMEN1KMT2AACP3UGT2B7
SCHEMBL17795038 0.87 BRD4 (0.53) ACHEMEN1KMT2AACP3UGT2B7
SCHEMBL2812852 0.85 UGT2B7 (0.56) MEN1KMT2AUGT2B7BRD4BRD2
SCHEMBL9331663 0.85 UGT2B7 (0.56) MEN1KMT2AUGT2B7BRD4BRD2
SCHEMBL9331659 0.85 UGT2B7 (0.56) MEN1KMT2AUGT2B7BRD4BRD2
SCHEMBL9334664 0.85 UGT2B7 (0.56) MEN1KMT2AUGT2B7BRD4BRD2
SCHEMBL6055386 0.84 ACHE (0.48) ACHEACP3EPHX1TP53TDP1
SCHEMBL6035448 0.83 ACHE (0.52) ACHEACP3EPHX1TP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114292385-B Nitrogen-containing porous organic polymer composite material and preparation method and application thereof 苏州大学 2023-09-05 CN claimed
CN-114292385-A Nitrogen-containing porous organic polymer composite material and preparation method and application thereof 苏州大学 2022-04-08 CN claimed
CN-111621031-B Preparation method and application of mimic enzyme MOF-based chiral separation material 合肥工业大学 2022-03-18 CN claimed
US-20200384451-A1 PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2020-12-10 US claimed
CN-111621031-A Preparation method and application of mimic enzyme MOF-based chiral separation material 合肥工业大学 2020-09-04 CN claimed
US-20260000642-A1 PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS TAY THERAPEUTICS LTD (GB) 2026-01-01 US disclosed
US-20250263370-A1 PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS Tay Therapeutics Limited (GB) 2025-08-21 US disclosed
EP-4558224-A1 PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS Tay Therapeutics Limited (GB) 2025-05-28 EP disclosed
CN-119977739-A Method for preparing nitrile compound by oxidizing alcohol compound to break C-C bond 中国科学院大连化学物理研究所 2025-05-13 CN disclosed
CN-118807715-B Zn-MOF-PDMS chiral porous liquid material and application thereof 云南师范大学 2025-05-09 CN disclosed
CN-119798058-A Preparation method of alpha-alkyl ketone derivative 浙江工业大学 2025-04-11 CN disclosed
WO-2025022124-A2 METHODS FOR DEPOLYMERISING AND REPOLYMERISING Epoch Biodesign Ltd (GB) 2025-01-30 WO disclosed
EP-0523697-A1 Color-developing compositions and their use MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-01-20 EP disclosed
EP-0347694-B1 PYRETHROIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COMBATING PESTS BASF Aktiengesellschaft (DE) 1992-08-26 EP disclosed
US-5023366-A Reacted with a benzyl halide, alcohol or ether; for pressure sensitive elements MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1991-06-11 US disclosed
EP-0411150-A1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-06 EP disclosed
EP-0268878-A2 Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents MITSUI TOATSU CHEMICALS, Inc. (JP) 1988-06-01 EP disclosed
EP-0021848-B1 PROCESS AND APPARATUS FOR THE PREPARATION OF PHENOLS MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1983-04-13 EP disclosed
US-4334108-A Process and apparatus for preparation of phenols MITSU PETROCHEMICAL INDUSTRIES LTD. (JP) 1982-06-08 US disclosed
EP-0021848-A1 Process and apparatus for the preparation of phenols MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1981-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200384451-A1 PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF CPNE4, PPOX, PDCD5 ACHE 843/4885MEN1 472/4885KMT2A 927/4885
US-20260000642-A1 PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS BET1, BRD4, PHKB ACHE 4667/4885MEN1 4792/4885KMT2A 2090/4885
US-20250263370-A1 PYRROLES AND IMIDAZOLES AS BET PROTEIN INHIBITORS BET1, PHKB, BRD4 ACHE 3965/4885MEN1 4098/4885KMT2A 2187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.